Tremor News and Research

Latest Tremor News and Research

FDA approves scalpel-free brain surgery to treat essential tremor

The Food and Drug Administration has approved the first focused ultrasound device to treat essential tremor, the most common movement disorder, in patients who do not respond to medication.

21 Jul 2016

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors.

11 Jul 2016

Study finds no substantial link between gadolinium exposure and parkinsonism

In a study appearing in the July 5 issue of JAMA, Blayne Welk, M.D., M.Sc., of Western University, London, Canada, and colleagues conducted a study to assess the association between gadolinium exposure and parkinsonism, a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination.

6 Jul 2016

Telemedicine shows promise in Parkinson’s disease care

Like countless other patients, Ann Johnson, a retired veterinarian, has been willing to travel long distances and devote an entire day to be treated by a specialist at Rush University Medical Center. But a recent appointment lasted less than 30 minutes, and the only travel was to her living room.

29 Jun 2016

Mice studies reveal new insights into neurons that cause symptoms of Rett syndrome

Two studies in mice from Baylor College of Medicine, Texas, reveal new insights into neurons that mediate symptoms typical of the postnatal neurological disorder Rett syndrome.

29 Jun 2016

New study reveals increasing trend in Parkinson's disease over 30 years

The incidence of Parkinson's disease and parkinsonism increased significantly in 30 years from 1976 to 2005, Mayo Clinic researchers reported today in a study in JAMA Neurology.

21 Jun 2016

Motor subtypes of PD show different prognostic traits

The severity of postural instability and gait difficulty appears to be a useful indicator of Parkinson's disease progression, researchers report.

4 Jun 2016

TSRI scientists develop first drug candidate that neutralizes disease-causing RNA repeats

In an important new study with implications for the treatment of dozens of incurable diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time created a drug candidate that attacks and neutralizes the RNA structure that causes an incurable progressive, inherited disease involving a gradual loss of control over body movement.

1 Jun 2016

Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease.

30 Apr 2016

Researchers explore changes in Parkinson's-affected cells at different stages of the disease

It's an unsettling thought: You could be walking around for 20 years developing Parkinson's disease and not even know it.

29 Apr 2016

Two London students make innovative medical devices to improve lives of people with Parkinson’s disease

Two London students, who have invented separate pieces of medical technology that could help revolutionise the lives of people with Parkinson’s disease, could soon see their innovative devices available to millions of sufferers after they were shortlisted for a prestigious award.

27 Apr 2016

FAU's clinical trial to evaluate efficacy of RVT-101 tablet for Lewy body dementia

Florida Atlantic University's Charles E. Schmidt College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for Lewy body dementia (LBD), the second-most common dementia after Alzheimer's disease. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.

22 Apr 2016

AAN’s updated guideline on botulinum toxin use covers four neurologic disorders

The American Academy of Neurology has updated its 2008 guidelines on the use of botulinum toxin for spasticity, cervical dystonia, blepharospasm and migraine headache, based on recent research.

19 Apr 2016

Cardiac drug combats muscle cramps in ALS

A phase II study shows that the sodium channel blocker mexiletine has no specific safety concerns in patients with amyotrophic lateral sclerosis and, moreover, markedly reduces muscle cramps.

1 Mar 2016

Pitt experts lead gene therapy clinical trial in Parkinson's disease patients

Experts at the University of Pittsburgh School of Medicine are leading the second arm of a clinical trial using gene therapy to relieve the symptoms of tremor and mobility impairment in patients with Parkinson's disease.

23 Feb 2016

Study unravels physiological signature of fear memory within prefrontalamygdala networks

Fear response to traumatic or threatening situations helps us evade or escape danger. At the same time fear response is learned in the form of association between stimulus or situation and the presence of a stressor.

23 Feb 2016

Stem cell research reveals how Parkinson’s spreads from cell to cell

Stem cell research published today offers up new clues as to how Parkinson’s spreads from cell to cell, a process which has evaded researchers for decades.

19 Feb 2016

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2015.

12 Feb 2016

Saliva gland test may help diagnose early Parkinson's disease

Researchers from Mayo Clinic in Arizona and Banner Sun Health Research Institute have determined that testing a portion of a person's submandibular gland may be a way to diagnose early Parkinson's disease. The study was published this month in Movement Disorders, the official journal of the International Parkinson and Movement Disorders Society.

2 Feb 2016

Specific deep-brain circuit's firing frequency can alter forebrain activity, alertness levels

Adjusting a specific deep-brain circuit's firing frequency immediately and dramatically alters rats' forebrain activity and alertness levels, Stanford University School of Medicine investigators have shown.

11 Dec 2015

Tremor News and Research

Latest Tremor News and Research

FDA approves scalpel-free brain surgery to treat essential tremor

FDA approves new ExAblate Neuro to treat patients with essential tremor

Study finds no substantial link between gadolinium exposure and parkinsonism

Telemedicine shows promise in Parkinson’s disease care

Mice studies reveal new insights into neurons that cause symptoms of Rett syndrome

New study reveals increasing trend in Parkinson's disease over 30 years

Motor subtypes of PD show different prognostic traits

TSRI scientists develop first drug candidate that neutralizes disease-causing RNA repeats

Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

Researchers explore changes in Parkinson's-affected cells at different stages of the disease

Two London students make innovative medical devices to improve lives of people with Parkinson’s disease

FAU's clinical trial to evaluate efficacy of RVT-101 tablet for Lewy body dementia

AAN’s updated guideline on botulinum toxin use covers four neurologic disorders

Cardiac drug combats muscle cramps in ALS

Pitt experts lead gene therapy clinical trial in Parkinson's disease patients

Study unravels physiological signature of fear memory within prefrontalamygdala networks

Stem cell research reveals how Parkinson’s spreads from cell to cell

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Saliva gland test may help diagnose early Parkinson's disease

Specific deep-brain circuit's firing frequency can alter forebrain activity, alertness levels

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Tremor News and Research

Latest Tremor News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in